Richard Ammer

Richard is the Managing Owner and Chief Executive Officer of MEDICE Arzneimittel Pütter GmbH & Co. KG (Medice), a family-owned pharmaceutical company based in Iserlohn, Germany. Medice is the #1 ranked pharmaceutical company in sales of prescription ADHD medications across Europe. Richard has served as Medice’s general manager since 2003, responsible for research & development, medical & regulatory affairs, manufacturing, market access, and international marketing & distribution. Richard graduated with a degree in medicine from Technical University, Munich, and an internship at Harvard Medical School, Boston. His basic and clinical research on atrial fibrillation for which he obtained his Ph.D. was awarded by the European Society in Cardiology with the Young Investigator Award in Basic Science in 2001. Specializing in cardiac and renal care, Richard pursued his clinical education in internal medicine at Massachusetts General Hospital in Boston (1996-2000), the German Heart Center (2000-2001), and the University Hospital in Muenster (2001). Richard also pursued studies in business administration and economics at University St. Gallen (1992-1996) and Harvard Extension School (1996 -1999), completing his Ph.D. in 2005. Since 2001, Richard has served as an assistant professor at University St. Gallen (Switzerland). Since 2006, Richard has served as a board member and Vice President of the German Pharmaceutical Association with a focus on R&D.